Development of a Specific Substrate-Inhibitor Panel (Liver-on-a-Chip) for Evaluation of Cytochrome P450 Activity.

about

Development of a Specific Substrate-Inhibitor Panel (Liver-on-a-Chip) for Evaluation of Cytochrome P450 Activity.

Item

http://www.wikidata.org/entity/Q46455202

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Development of a Specific Subs ...... n of Cytochrome P450 Activity.

@en

Development of a Specific Substrate-Inhibitor Panel

@nl

type

Item

label

Development of a Specific Subs ...... n of Cytochrome P450 Activity.

@en

Development of a Specific Substrate-Inhibitor Panel

@nl

prefLabel

Development of a Specific Subs ...... n of Cytochrome P450 Activity.

@en

Development of a Specific Substrate-Inhibitor Panel

@nl

P1476

Development of a Specific Subs ...... n of Cytochrome P450 Activity.

@en

P2093

A A Poloznikov

http://www.w3.org/2001/XMLSchema#string

A A Zakhariants

http://www.w3.org/2001/XMLSchema#string

D A Sakharov

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline.

CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme

Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical Research

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.

Chip-based liver equivalents for toxicity testing--organotypicalness versus cost-efficient high throughput.

A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing.

Interaction of new sulfaphenazole derivatives with human liver cytochrome p450 2Cs: structural determinants required for selective recognition by CYP 2C9 and for inhibition of human CYP 2Cs.

(+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19.

Effect of Circulation Parameters on Functional Status of HepaRG Spheroids Cultured in Microbioreactor.

P2888

s10517-016-3567-z

P304

170-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10517-016-3567-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P50

Maxim Shkurnikov

Olga Burmistrova

P577

2016-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27882460

http://www.w3.org/2001/XMLSchema#string